IL31 and Alzheimer disease: Beyond the well-established roles of histamine, IL-31, and neuropeptides in sensory modulation, purinergic signaling mediated by ATP has recently emerged as a critical complementary pathway in the sensitization of the mast cell–neuron axis in AD, with particular attention to the P2X3 receptor.